Overall, these studies demonstrate that deletion of Socs3 in myeloid cells contributes to hyper-activation and enhanced inflammation, leading us to postulate that Socs3-deficient myeloid cells may play a potential role in the pathogenesis of DSS-induced colitis. The gene discussed is SOCS3; the disease is colitis.